Emcure Pharmaceuticals Limited Stock

Stocks

EMCURE

INE168P01015

Pharmaceuticals

End-of-day quote NSE India S.E. 16/07/2026 5-day change 1st Jan Change
1,802.70 INR +0.69% Intraday chart for Emcure Pharmaceuticals Limited -0.36% +32.11%

Valuation: Emcure Pharmaceuticals Limited

Market Cap 342B 3.55B 3.1B 2.87B 2.63B 4.98B 5.07B 34.19B 13.43B 167B 13.32B 13.03B 576B P/E 2026
32.7x
P/E 2027 * 29.7x
Enterprise Value 349B 3.62B 3.16B 2.92B 2.68B 5.08B 5.17B 34.87B 13.7B 170B 13.58B 13.28B 588B EV / Sales 2026
3.33x
EV / Sales 2027 * 3.32x
Free-Float
18.3%
Yield 2026
0.23%
Yield 2027 * 0.21%
1 day+0.69%
1 week-0.36%
Current month-1.81%
1 month+5.69%
3 months+9.47%
6 months+14.78%
Current year+32.11%
1 week 1,780.1
Extreme 1780.1
1,840
1 month 1,704.8
Extreme 1704.8
1,944
Current year 1,381
Extreme 1381
1,944
1 year 1,260
Extreme 1260
1,944
3 years 889
Extreme 889
1,944
5 years 889
Extreme 889
1,944
10 years 889
Extreme 889
1,944
Manager TitleAgeSince
Chief Executive Officer 75 16/04/1981
Director of Finance/CFO - 01/10/2003
Compliance Officer - 04/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 72 23/07/2001
Director/Board Member 75 16/04/1981
Change 5-day change 1-year change 3-year change Capi.($)
+0.69%-0.36%+32.40% - 3.53B
+1.08%-3.84%+51.50%+160.13% 1,031B
+1.19%-5.10%+61.09%+56.36% 595B
+4.21%+0.65%+36.48%+87.04% 431B
+0.42%-0.99%+30.04%+22.27% 326B
+1.03%-2.10%+28.32%+45.08% 277B
+0.49%-11.32%+20.31%+22.32% 263B
+1.59%+3.91%-22.47%-36.84% 224B
+3.70%+0.98%+27.03%+63.38% 193B
+3.49%+0.35%+24.98%+76.58% 164B
Average +1.88%-3.48%+28.97%+55.15% 350.78B
Weighted average by Cap. +1.81%-4.30%+37.79%+79.43%

Financials

2026 2027 *
Net sales 91.56B 950M 831M 768M 705M 1.33B 1.36B 9.16B 3.6B 44.71B 3.57B 3.49B 154B 104B 1.08B 947M 876M 804M 1.52B 1.55B 10.44B 4.1B 50.98B 4.07B 3.98B 176B
Net income 9.81B 102M 88.99M 82.3M 75.52M 143M 145M 982M 386M 4.79B 382M 374M 16.54B 11.5B 119M 104M 96.44M 88.5M 167M 170M 1.15B 452M 5.61B 448M 438M 19.38B
Net Debt 6.75B 70.04M 61.22M 56.62M 51.96M 98.33M 100M 675M 265M 3.3B 263M 257M 11.38B 4.56B 47.37M 41.41M 38.29M 35.14M 66.5M 67.66M 457M 179M 2.23B 178M 174M 7.7B
Logo Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and Active Pharmaceutical Ingredient (APIs). It operates across a wide scope of areas, including Gynecology, Cardiovascular, HIV Antivirals, VMN (Vitamins, Minerals & Nutrients), Pain/Analgesics, Nephrology, Oncology, Anti-Infective, Respiratory, CNS. Its brands include Orofer XT and Pause (Gynecological), Proxym (pain), Tenectase (CNS), Vylda (diabetology), Vitanova (VMN). Its API products include S-Amlodipine, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (Tenecteplase), Vintor (Erythropoietin), TENECTASE (Tenecteplase). It has developed two platforms: Mammalian and Microbial.
Employees
6,731
Date Price Change Volume
16/07/26 ₹1,802.70 +0.69% 120,724
15/07/26 ₹1,790.30 -1.09% 95,679
14/07/26 ₹1,810.10 +0.94% 138,088
13/07/26 ₹1,793.30 -1.16% 87,267
10/07/26 ₹1,814.40 +0.27% 74,788
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,802.70INR
Average target price
1,913.50INR
Spread / Average Target
+6.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMCURE Stock